164 related articles for article (PubMed ID: 32338437)
1. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
[TBL] [Abstract][Full Text] [Related]
2. [Expression of A-kinase anchor protein 95, cyclin E2, and connexin 43 in lung cancer tissue, clinical significance of their expression, and their expression correlation].
Chen YD; Chen XX; Shen LN; Liang FC; Ding Y; Yu XY; Xue MQ; Zhang YX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Oct; 30(10):725-9. PubMed ID: 23256994
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.
Qi F; Yuan Y; Zhi X; Huang Q; Chen Y; Zhuang W; Zhang D; Teng B; Kong X; Zhang Y
Int J Clin Exp Pathol; 2015; 8(2):1666-73. PubMed ID: 25973052
[TBL] [Abstract][Full Text] [Related]
4. Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.
Huang P; Sun Q; Zhuang W; Peng K; Wang D; Yao Y; Guo D; Zhang L; Shen C; Sun M; Tang C; Teng B; Zhang Y
Thorac Cancer; 2017 Sep; 8(5):495-500. PubMed ID: 28755423
[TBL] [Abstract][Full Text] [Related]
5. Roles of Cx43 and AKAP95 in ovarian cancer tissues in G1/S phase.
Liu W; Hua S; Dai Y; Yuan Y; Yang J; Deng J; Huo Y; Chen X; Teng B; Yu X; Zhang Y
Int J Clin Exp Pathol; 2015; 8(11):14315-24. PubMed ID: 26823747
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].
Hu SX; Kong XY; Yuan YY; Teng BG; Zhi XH; Zhuang WX; Yu XY; Liu WZ; Zhang YX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Dec; 31(12):890-4. PubMed ID: 24370359
[TBL] [Abstract][Full Text] [Related]
7. G1/S Cyclins interact with regulatory subunit of PKA via A-kinase anchoring protein, AKAP95.
Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
Cell Cycle; 2006 Jun; 5(11):1217-22. PubMed ID: 16721056
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells.
Chen X; Kong X; Zhuang W; Teng B; Yu X; Hua S; Wang S; Liang F; Ma D; Zhang S; Zou X; Dai Y; Yang W; Zhang Y
Sci Rep; 2016 Feb; 6():21224. PubMed ID: 26880274
[TBL] [Abstract][Full Text] [Related]
9. AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.
Kong XY; Zhang DC; Zhuang WX; Hua SH; Dai Y; Yuan YY; Feng LL; Huang Q; Teng BG; Yu XY; Liu WZ; Zhang YX
Am J Transl Res; 2016; 8(2):811-26. PubMed ID: 27158371
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the protein expression levels of A-kinase anchor protein95, p-retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues.
Wang S; Wang K; Deng Z; Jiang Z; Wang D; Yao Y; Guo D; Kong X; Guan Z; Zhang Y
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e162-e166. PubMed ID: 30990963
[TBL] [Abstract][Full Text] [Related]
12. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclin D1 overexpression on G1 progression-related events.
Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
16. A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
Biochem J; 2004 Mar; 378(Pt 2):673-9. PubMed ID: 14641107
[TBL] [Abstract][Full Text] [Related]
17. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo.
Odajima J; Saini S; Jung P; Ndassa-Colday Y; Ficaro S; Geng Y; Marco E; Michowski W; Wang YE; DeCaprio JA; Litovchick L; Marto J; Sicinski P
PLoS Genet; 2016 Nov; 12(11):e1006429. PubMed ID: 27828963
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
RodrÃguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
[TBL] [Abstract][Full Text] [Related]
20. Kinase-independent function of E-type cyclins in liver cancer.
Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
